ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,739,961 | -10.0% | 2,578,382 | +3.4% | 0.01% | -14.3% |
| Q2 2023 | $59,739,418 | +32.8% | 2,494,338 | +4.4% | 0.01% | +16.7% |
| Q1 2023 | $44,984,844 | +122782.6% | 2,390,267 | +3.9% | 0.01% | +20.0% |
| Q4 2022 | $36,608 | -99.9% | 2,299,499 | +3.5% | 0.01% | -16.7% |
| Q3 2022 | $36,338,000 | +19.3% | 2,221,151 | +2.8% | 0.01% | +50.0% |
| Q2 2022 | $30,448,000 | -42.9% | 2,160,984 | -1.9% | 0.00% | -42.9% |
| Q1 2022 | $53,342,000 | +5.6% | 2,202,425 | +1.8% | 0.01% | +16.7% |
| Q4 2021 | $50,511,000 | +50.5% | 2,164,152 | +7.1% | 0.01% | +20.0% |
| Q3 2021 | $33,571,000 | -33.7% | 2,021,152 | -2.6% | 0.01% | -28.6% |
| Q2 2021 | $50,616,000 | +33.8% | 2,075,300 | +41.5% | 0.01% | +16.7% |
| Q1 2021 | $37,835,000 | -50.1% | 1,466,510 | +3.3% | 0.01% | -53.8% |
| Q4 2020 | $75,871,000 | +38.3% | 1,419,212 | +6.7% | 0.01% | +18.2% |
| Q3 2020 | $54,875,000 | -17.4% | 1,330,316 | -2.9% | 0.01% | -21.4% |
| Q2 2020 | $66,428,000 | -9.0% | 1,370,503 | -20.7% | 0.01% | -26.3% |
| Q1 2020 | $73,010,000 | -47.4% | 1,728,070 | -46.7% | 0.02% | +35.7% |
| Q4 2019 | $138,696,000 | +158.2% | 3,242,118 | +117.2% | 0.01% | +7.7% |
| Q3 2019 | $53,714,000 | +35.1% | 1,492,494 | +0.3% | 0.01% | +30.0% |
| Q2 2019 | $39,769,000 | +4.2% | 1,487,832 | +4.7% | 0.01% | 0.0% |
| Q1 2019 | $38,171,000 | -5.2% | 1,421,663 | -42.9% | 0.01% | +66.7% |
| Q4 2018 | $40,260,000 | +81.7% | 2,489,878 | +133.3% | 0.01% | 0.0% |
| Q3 2018 | $22,155,000 | +44.4% | 1,067,238 | +6.2% | 0.01% | +20.0% |
| Q2 2018 | $15,340,000 | -24.6% | 1,004,633 | +10.9% | 0.01% | -28.6% |
| Q1 2018 | $20,347,000 | -22.3% | 905,549 | +4.1% | 0.01% | -22.2% |
| Q4 2017 | $26,195,000 | -17.7% | 869,977 | +2.9% | 0.01% | -25.0% |
| Q3 2017 | $31,836,000 | +44.4% | 845,130 | +6.9% | 0.01% | +33.3% |
| Q2 2017 | $22,043,000 | -15.7% | 790,410 | +3.9% | 0.01% | -18.2% |
| Q1 2017 | $26,157,000 | +30.1% | 760,832 | +9.1% | 0.01% | +22.2% |
| Q4 2016 | $20,113,000 | -5.9% | 697,411 | +3.8% | 0.01% | -18.2% |
| Q3 2016 | $21,366,000 | +1.6% | 671,683 | +3.6% | 0.01% | 0.0% |
| Q2 2016 | $21,036,000 | +11.5% | 648,089 | -4.0% | 0.01% | +10.0% |
| Q1 2016 | $18,873,000 | -3.5% | 675,017 | +23.0% | 0.01% | -9.1% |
| Q4 2015 | $19,566,000 | +10.8% | 548,848 | +2.8% | 0.01% | 0.0% |
| Q3 2015 | $17,652,000 | -18.8% | 533,790 | +2.8% | 0.01% | -8.3% |
| Q2 2015 | $21,748,000 | +32.4% | 519,313 | +3.1% | 0.01% | +33.3% |
| Q1 2015 | $16,420,000 | +5.7% | 503,886 | +3.0% | 0.01% | 0.0% |
| Q4 2014 | $15,535,000 | +31.3% | 489,316 | +2.4% | 0.01% | +12.5% |
| Q3 2014 | $11,836,000 | +10.9% | 478,058 | +1.2% | 0.01% | +14.3% |
| Q2 2014 | $10,668,000 | -1.0% | 472,252 | +6.6% | 0.01% | 0.0% |
| Q1 2014 | $10,776,000 | +12.4% | 442,915 | +15.5% | 0.01% | 0.0% |
| Q4 2013 | $9,586,000 | +5.6% | 383,626 | +16.1% | 0.01% | 0.0% |
| Q3 2013 | $9,076,000 | +65.2% | 330,386 | +9.2% | 0.01% | +40.0% |
| Q2 2013 | $5,493,000 | – | 302,632 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
| Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
| RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
| Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
| Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
| EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
| EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
| SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |